[Analysis of selected spirometric parameters and results of therapy with nedocromil sodium in patients with asthma].

Abstract

The effect of 12 weeks therapy with nedocromil sodium given as MDI-aerosol, 8 mg/daily in a group of 20 atopic asthmatic patients was studied. The selected spirometric parameters (PEF, FEV1, FVC, FEF25-75%, Raw) and clinical symptoms of bronchial asthma (dyspnoea, cough, sputum) were assessed. Additionally the percentage reduction of bronchodilators usage was obtained. A significant improvement was observed in spirometric parameters. A statistically significant reduction in clinical symptoms of bronchial asthma and bronchodilators usage was noted.

• Authors: R Rutkowski, Z Siergiejko, S Chyrek-Borowska
• Journal: Pneumonologia i alergologia polska (Pneumonol Alergol Pol) Vol. 61 Issue 7-8 Pg. 377-82 ( 1993) ISSN: 0867-7077 [Print] Poland
• Vernacular Title: Ocena wybranych wskaźników spirometrycznych oraz wyników leczenia nedokromilem sodu chorych na dychawice oskrzelowa.
• PMID: 8401344 (Publication Type: English Abstract, Journal Article)

Chemical References

• Nedocromil

Topics

• Adult
• Asthma (drug therapy, physiopathology)
• Female
• Humans
• Male
• Nedocromil (therapeutic use)
• Pulmonary Ventilation (drug effects)
• Spirometry